Institute of Cancer Research Opens Centre for Cancer Drug Discovery 

Published 12-7-2020
  • Institute of Cancer Research - Centre for Cancer Drug Discovery 
  • Institute of Cancer Research - Centre for Cancer Drug Discovery 
  • Institute of Cancer Research - Centre for Cancer Drug Discovery 
  • Institute of Cancer Research - Centre for Cancer Drug Discovery 
  • Institute of Cancer Research - Centre for Cancer Drug Discovery 
  • Institute of Cancer Research - Centre for Cancer Drug Discovery 

    Courtesy of the Institute of Cancer Research.

  • Institute of Cancer Research - Centre for Cancer Drug Discovery 

    Courtesy of the Institute of Cancer Research.

  • Institute of Cancer Research - Centre for Cancer Drug Discovery 

    Courtesy of the Institute of Cancer Research.

  • Institute of Cancer Research - Centre for Cancer Drug Discovery 

    Courtesy of the Institute of Cancer Research.

  • Institute of Cancer Research - Centre for Cancer Drug Discovery 

    Courtesy of the Institute of Cancer Research.

The Institute of Cancer Research (ICR) opened the £75 million Centre for Cancer Drug Discovery in London in November of 2020. Located in the borough of Sutton, the 78,580-sf facility features team laboratories where biologists, evolutionary scientists, chemists, pharmacologists, data scientists, and clinicians can discover new solutions for cancer evolution and drug resistance. Accommodating 300 investigators, the multidisciplinary building provides offices, collaboration zones, meeting rooms, and labs for biology, wet chemistry, computation, protein production, mass spectrometry, and analytical screening. The structure also houses a 3D visualization chamber, an NMR suite, and the Centre for Evolution and Cancer. The project is one of the flagship buildings at the London Cancer Hub, which is being developed by ICR, the National Health Service, and Sutton Council as a global nexus for cancer innovation.